Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Rhea-AI Summary
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has announced its participation in the 2024 Cantor Global Healthcare Conference. The company's management team will engage in a fireside chat on Tuesday, September 17, 2024, at 8:00 AM ET in New York.
Investors and interested parties can access a webcast of the fireside chat through the 'Events' page in the 'Investors' section of Aclaris' website, www.aclaristx.com. The webcast will remain archived on the company's website for a minimum of 30 days, allowing for later viewing.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ACRS declined 0.85%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York.
A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
investors@aclaristx.com
FAQ
When is Aclaris Therapeutics (ACRS) participating in the 2024 Cantor Global Healthcare Conference?
How can investors access Aclaris Therapeutics' (ACRS) fireside chat at the 2024 Cantor Global Healthcare Conference?
How long will the webcast of Aclaris Therapeutics' (ACRS) fireside chat be available?
What is the focus of Aclaris Therapeutics (ACRS) as a company?
